Replimune Group, Inc. REPL
NASDAQ · United States · Health Technology
$13.48+0.03 (+0.22%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q1 2027 | 2026-08-14 | -0.72 | -0.77 | +6.5% | — | — | -3.7%$15.19→$14.63 |
| Q1 2026 | 2026-08-14 | -0.72 | -0.69 | -3.7% | $0 | — | -3.7%$15.19→$14.63 |
| Q4 2026 | 2026-06-29 | -0.76 | -0.72 | -5.6% | — | — | -4.8%$11.63→$11.07 |
| Q3 2026 | 2026-02-03 | -0.77 | -0.82 | +6.1% | — | — | +0.4%$6.97→$7.00 |
| Q3 2025 | 2025-11-06 | -0.90 | -0.87 | -3.4% | — | — | -3.1%$8.58→$8.31 |
| Q4 2025 | 2025-05-22 | -0.82 | -0.69 | -18.8% | — | — | — |
| Q3 2025 | 2025-02-12 | -0.79 | -0.72 | -9.7% | — | — | — |
| Q2 2025 | 2024-11-12 | -0.68 | -0.74 | +8.1% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.